LABT logo

Lakewood-Amedex Biotherapeutics, Inc.

LABT
0.00
USD
+0.00+0.00%

Lakewood-Amedex Biotherapeutics, Inc. at a glance

Open LABT on Vela

Lakewood-Amedex Biotherapeutics, Inc. (LABT) is a Healthcare company in the Biotechnology industry, headquartered in University Park, FL, with about 5 employees. Its shares trade on NASDAQ, and its IPO date is April 23, 2026. With a market capitalization of $542,704, LABT is a small-cap stock.

It trades an average of 1.8 million shares a day.

In its latest reported quarter (results released August 13, 2026), Lakewood-Amedex Biotherapeutics, Inc. posted earnings of -$2.75 per share, against an estimate of -$2.66.

Figures as of October 25, 2026, from market data providers. Descriptive only, not financial advice.

LABT: Frequently asked questions

As of October 25, 2026, Lakewood-Amedex Biotherapeutics, Inc. has a market capitalization of $542,704, making it a small-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.